Nephrology, Dialysis, Transplantation

Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD

By Hiddo J.L. Heerspink, Clare Gabrielle Arnott, Jonathan Barratt, Vlado Perkovic

Trial in peopleInterventions

The paper

Hiddo J.L. Heerspink, Clare Gabrielle Arnott, Jonathan Barratt, Vlado Perkovic

University Medical Center Groningen; UNSW Sydney

Nephrology, Dialysis, Transplantation, 4 Aug 2026

doi.org/10.1093/ndt/gfag172 PubMed 42550497

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes